Evidence map›Paper›PMID 40441141›Full record

ArticleCell genomics2025

Unraveling an enhancer-silencer regulatory element showing epistatic interaction with a variant that escaped genome-wide association studies.

Mathieu Adjemout, Samia Nisar, Amélie Escandell, Romain Torres, Magali Torres, Hong Thu Nguyen Huu, Alassane Thiam, Iris Manosalva, Babacar Mbengue, Alioune Dieye and 4 more

Abstract read
In one paragraph

Article in Cell genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Introducing the EpGEpigenomes · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mathieu AdjemoutAix Marseille University, INSERM, TAGC, MarMaRa Institute, Marseille, France.
Samia NisarAix Marseille University, INSERM, TAGC, MarMaRa Institute, Marseille, France.
Amélie EscandellAix Marseille University, INSERM, TAGC, MarMaRa Institute, Marseille, France.
Romain TorresInfinity, Toulouse Institute for Infectious and Inflammatory Diseases, University of Toulouse, Inserm U1291, CNRS U5051 Toulouse, France.
Magali TorresAix Marseille University, INSERM, TAGC, MarMaRa Institute, Marseille, France.
Hong Thu Nguyen HuuAix Marseille University, INSERM, TAGC, MarMaRa Institute, Marseille, France.
Alassane ThiamUnité d'Immunogénétique, Institut Pasteur de Dakar, Dakar BP 220, Senegal.
Iris ManosalvaAix Marseille University, INSERM, TAGC, MarMaRa Institute, Marseille, France.
Babacar MbengueService d'Immunologie, Université Cheikh Anta Diop de Dakar, Dakar BP5005, Senegal.
Alioune DieyeService d'Immunologie, Université Cheikh Anta Diop de Dakar, Dakar BP5005, Senegal.
Véronique AdoueInfinity, Toulouse Institute for Infectious and Inflammatory Diseases, University of Toulouse, Inserm U1291, CNRS U5051 Toulouse, France.
Salvatore SpicugliaAix Marseille University, INSERM, TAGC, MarMaRa Institute, Marseille, France.
Pascal RihetAix Marseille University, INSERM, TAGC, MarMaRa Institute, Marseille, France.
Sandrine MarquetAix Marseille University, INSERM, TAGC, MarMaRa Institute, Marseille, France; CNRS, Marseille, France. Electronic address: sandrine.marquet@univ-amu.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulation of gene expression has recently been complicated by identifying Epromoters, a subset of promoters with enhancer function. Here, we uncovered a dual cis-regulatory element, "ESpromoter," exhibiting both enhancer and silencer function as a regulator of the nearby genes ATP2B4 and LAX1 in single human T cells. Through an integrative approach, we pinpointed functional rs11240391, a severe malaria-risk variant that escapes detection in genome-wide association studies, challenging conventional strategies for identifying causal variants. CRISPR-modified cells demonstrated the regulatory effect of ESpromoter and rs11240391 on LAX1 expression and T cell activation. Furthermore, our findings revealed an epistatic interaction between ESpromoter SNPs and rs11240391, impacting severe malaria susceptibility by further reducing LAX1 expression. This groundbreaking discovery challenges the conventional enhancer-silencer dichotomy. It highlights the sophistication of transcriptional regulation and argues for an integrated approach combining genetics, epigenetics, and genomics to identify new therapeutic targets for complex diseases.

Indexed as

Enhancer Elements, GeneticEpistasis, GeneticSilencer Elements, TranscriptionalGene Expression RegulationGenome-Wide Association StudyHumansMalariaPolymorphism, Single NucleotideT-Lymphocytescis-regulatory elementsdual functionenhancer-silencerepistatic interactionfunctional variantssevere malariaT cell activationtranscriptional regulation

Identifiers

PMID40441141
PMCPMC12278644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.